CYP2C19 phenotype in South?East Asian Acute Coronary Syndrome patients and impact on major adverse cardiovascular events
10.1111/jcpt.13062
Saved in:
Main Authors: | Tan DS, Aw JWX, Winther M, Goh LL, Ong HY, Wee E, Liu J, Ho HK, J Clin Pharm Ther |
---|---|
Other Authors: | PHARMACY |
Published: |
Wiley
2020
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/176980 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Effects of the CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: A meta-analysis
by: Mohitosh Biswas, et al.
Published: (2022) -
Effects of the CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: A meta-analysis
by: Biswas M.
Published: (2023) -
Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
by: Armstrong, E.J, et al.
Published: (2020) -
Letter regarding Article, "Clinical outcomes and sustainability of using CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention"
by: Aw JWX, et al.
Published: (2020) -
Cardio-ankle vascular index as a predictor of major adverse cardiovascular events in metabolic syndrome patients
by: Thosaphol Limpijankit, et al.
Published: (2022)